Searched for
ANIMAL HEALTH GENERICS
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsFrom a macro perspective, it is clearly a good time to be bullish. But as valuations remain high in parts of the market despite the recent ...- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analystsWe are in a phase in the US-Israel-Iran war where statements are made, then retracted. And, in a matter of just 48 hours, they are made all...
- Carlyle-backed Viyash Scientific buys Italy’s BioForLife for Rs 188 croreViyash Scientific, backed by Carlyle, is acquiring Italy's BioForLife for Rs. 188 crore. This move aims to build a leading global companion...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIf the US-Iran ceasefire holds, the markets may see some recovery. The movement of crude oil prices and its impact on the markets supports ...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
- Sequent-Viyash may soon have zero debt: Viyash founder and combined co's CEO-designate Hari Babu Bodepudi to inject ₹400 croreHari Babu Bodepudi is making a significant capital infusion into the newly merged Sequent Scientific and Viyash Life Sciences. This strateg...
- Zydus Lifesciences shares in focus after Ahmedabad oncology unit gets USFDA EIRZydus Lifesciences got a USFDA clearance upgrade for its Ahmedabad oncology plant, moving from OAI to VAI status after a June inspection—a ...
- Zydus Lifesciences shares in focus on USFDA nod for canine drugShares of Zydus Lifesciences are likely in focus after its subsidiary, ZyVet Animal Health, launched the first FDA-approved generic treatme...
- Sequent and Viyash Life merger plan gets shareholder approvalThe proposed merger of Sequent Scientific and Viyash Life Sciences, backed by Carlyle, has received overwhelming shareholder support. This ...
- Advent International to acquire stake in Felix PharmaceuticalsAdvent International is set to invest $175 million in Felix Pharmaceuticals, acquiring a significant minority stake. Felix Pharma, a Dublin...
- Big step towards better animal health: PM Modi on Cabinet's approval for revised livestock programPrime Minister Modi praised the Union Cabinet's approved revision of the Livestock Health & Disease Control Programme (LHDCP), highlighting...
- Boehringer Ingelheim India seeks system to keep tab on patent infringementIn terms of focus areas in the country, she said the drug firm is focussed on providing solutions for non communicable diseases like diabet...
- Cadila Healthcare Q2 results: Net profit zooms over 6-fold to Rs 3,002 cr on one-time gainConsolidated total revenue from operations of the company stood at Rs 3,784.8 crore for the quarter under consideration. It was Rs 3,658.9 ...
- Aurobindo Pharma to buy US animal health firm Cronus for Rs 420 crHyderabad-based Cronus is engaged in development, manufacturing and sale of veterinary pharmaceutical products and has a large exposure in ...
- SeQuent Scientific launches Citramox LA injection in 10 European countriesSeQuent said the new approval builds on the recent approvals of Tulazzin (Tulathromycin) and Halofusol (Halofuginone) in Europe.
- Pfizer to buy back $10 b in stock in line with its repurchase strategyThis is the fourth major share repurchase programme for New York-based company in past two-and-a-half years.
- Boehringer may buy Pfizer's animal health businessIn July last year, the world's second biggest pharma company, Pfizer had announced a spin off of its animal health and nutrition business.
- Global drug cos set sights on India’s veterinary marketAnimal healthcare in India is no longer an afterthought, as global pharmaceutical companies facing loss in revenues due to expiring drug pa...
Load More
